Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 1/2010

Content (16 Articles)

Review

Killer dendritic cells and their potential for cancer immunotherapy

Nicolas Larmonier, Jennifer Fraszczak, Daniela Lakomy, Bernard Bonnotte, Emmanuel Katsanis

Original Article

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

Cristina Garrido, Ignacio Algarra, Isabel Maleno, Julia Stefanski, Antonia Collado, Federico Garrido, Angel M. Garcia-Lora

Original Article

Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome

Franco Maria Venanzi, Massimiliano Petrini, Laura Fiammenghi, Elisabetta Bolli, Anna Maria Granato, Laura Ridolfi, Federica Gabrielli, Alessandra Barucca, Antonio Concetti, Ruggero Ridolfi, Angela Riccobon

Original Article

The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells

Evelien L. J. M. Smits, Nathalie Cools, Eva Lion, Kirsten Van Camp, Peter Ponsaerts, Zwi N. Berneman, Viggo F. I. Van Tendeloo

Original Article

Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice

Fuminori Abe, Alicia J. Dafferner, Moses Donkor, Sherry N. Westphal, Eric M. Scholar, Joyce C. Solheim, Rakesh K. Singh, Traci A. Hoke, James E. Talmadge

Original Article

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

Vittore Cereda, Diane J. Poole, Claudia Palena, Sudipto Das, Tapan K. Bera, Cinzia Remondo, James L. Gulley, Philip M. Arlen, Junko Yokokawa, Ira Pastan, Jeffrey Schlom, Kwong Y. Tsang

Original Article

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

Miroslaw J. Szczepanski, Marta Szajnik, Ann Welsh, Kenneth A. Foon, Theresa L. Whiteside, Michael Boyiadzis

Original Article

Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma

Alvaro Lladser, Karl Ljungberg, Helena Tufvesson, Marcella Tazzari, Anna-Karin Roos, Andrew F. G. Quest, Rolf Kiessling

Original Article

Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth

Pei-he Liang, Ke-qin Zhang, Gui-lian Xu, Yan-feng Li, Luo-fu Wang, Zhi-lin Nie, Jin Ye, Gang Wu, Cheng-guo Ge, Feng-shuo Jin

Original Article

Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells

Jacobus J. Bosch, Uzoma K. Iheagwara, Sarah Reid, Minu K. Srivastava, Julie Wolf, Michal Lotem, Bruce R. Ksander, Suzanne Ostrand-Rosenberg

Original Article

Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide

Ronald C. Hendrickson, Vito R. Cicinnati, Andreas Albers, Grzegorz Dworacki, Andrea Gambotto, Ornella Pagliano, Thomas Tüting, Jose I. Mayordomo, Carmen Visus, Ettore Appella, Jeffrey Shabanowitz, Donald F. Hunt, Albert B. DeLeo

Original Article

Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells

Ankit Saxena, Ambak Rai, Vinod Raina, Tulika Seth, Dipendra Kumar Mitra

Original Article

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

Vedran Radojcic, Karl B. Bezak, Mario Skarica, Maria A. Pletneva, Kiyoshi Yoshimura, Richard D. Schulick, Leo Luznik

Original Article

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen

Lavakumar Karyampudi, Christopher J. Krco, Kimberly R. Kalli, Courtney L. Erskine, Lynn C. Hartmann, Karin Goodman, James N. Ingle, Matthew J. Maurer, Aziza Nassar, Chao Yu, Mary L. Disis, Peter J. Wettstein, John D. Fikes, Melanie Beebe, Glenn Ishioka, Keith L. Knutson

Original Article

Comparative proteomical and metalloproteomical analyses of human plasma from patients with laryngeal cancer

Clarissa P. C. Gomes, Mirna S. Freire, Bruno R. B. Pires, Érico A. R. Vasconcelos, Thales L. Rocha, Maria de Fátima Grossi-de-Sá, Taia M. B. Rezende, Ângela Mehta, Rinaldo W. Pereira, Bernardo A. Petriz, Aparecido D. da Cruz, Igor C. Pescara, Octávio Luiz Franco

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine